Unlikely to cause harm — often a labeling or packaging issue.
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
| Distributed by / for | Teva Pharmaceuticals USA |
| NDC | 0591-3467-53 |
| Full product label | Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53. |
| Recalling firm | Teva Pharmaceuticals USA |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 401,750 cartons |
| Recall initiated | 2017-07-25 |
| Report date | 2017-08-09 |
| Recall completed | 2018-04-26 |
| Recall number | D-1039-2017 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | North Wales PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗